Envveno Medical Corp Stock Widgets and Gadgets
| NVNO Stock | USD 3.41 0.11 3.33% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- NVNO enVVeno Medical Corp
- Latest enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
- NVNO 3.41 0.11
- Low 3.3
- High 3.44
- Alpha -0.67
- Beta 0.68
- Return On Equity -0.59
- Return On Asset -0.37
- Current Valuation 12.57 M
- Shares Outstanding 17.54 M
- Shares Owned By Insiders 0.29 %
- Shares Owned By Institutions 29.76 %
- Number Of Shares Shorted 507.89 K
- Price To Book 1.26 X
- EBITDA (25.02 M)
- Net Income (23.52 M)
- Cash And Equivalents 37.48 M
- Cash Per Share 3.96 X
- Total Debt 1.4 M
- Debt To Equity 0.04 %
- Current Ratio 20.79 X
- Book Value Per Share 2.70 X
- Cash Flow From Operations (18.86 M)
- Short Ratio 3.63 X
- Earnings Per Share (1.29) X
- Target Price 18.0
- Number Of Employees 31
- Beta 1.22
- Market Capitalization 59.8 M
- Total Asset 48.63 M
- Retained Earnings (130.04 M)
- Working Capital 45.55 M
- Net Asset 48.63 M
- Accumulation Distribution 0.0407
- Daily Balance Of Power 0.7857
- Rate Of Daily Change 1.03
- Day Median Price 3.37
- Day Typical Price 3.38
- Market Facilitation Index 0.14
- Price Action Indicator 0.095
- Period Momentum Indicator 0.11
- Relative Strength Index 41.84
Market Snapshot Widget Example
DAX Index Germany | 19,323 0.92 | |
Taiwan Weighted Taiwan | 22,904 1.55 | |
PSI 20 Stock Portugal | 6,409 0.76 | |
CROBEX Croatia | 3,118 0.21 | |
Budapest SE Hungary | 79,552 0.41 | |
IDX 30 Jakarta Indonesia | 448.67 1.38 | |
ISEQ 20 Price Ireland | 1,611 0.16 | |
NYSE Comp USA | 20,123 0.78 | |
Tel Aviv 35 Israel | 2,260 0.33 | |
Coreshares Index Tracker South Afric | 1,101 1.57 | |
IPC MEXICO Mexico | 50,437 0.01 | |
KL Technology Malaysia | 59.16 0.08 | |
IBEX 35 Index Spain | 11,657 0.39 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,533 0.22 | |
SPASX Dividend Opportunities Australia | 1,702 1.08 | |
HNX 30 Vietnam | 467.97 0.39 | |
Bucharest BET-NG Romania | 1,220 0.53 | |
AMS Small Cap Netherlands | 1,183 0.81 | |
Oslo Exchange Mutual Norway | 1,422 0.44 | |
BEL Small Belgium | 8,105 0.52 | |
Basic Materials Brazil | 5,762 1.29 | |
Swiss Leader Price Switzerland | 1,932 1.11 | |
Fondo Mutuo ETF Chile | 1,374 0.04 | |
Athens General Comp Greece | 1,402 0.28 | |
Stock Exchange Of Thailand | 1,446 0.41 | |
PX Prague Stock Czech Repub | 1,697 0.37 | |
THE PHILIPPINE STOCK Philippines | 6,780 1.21 | |
WIG 30 Poland | 2,814 0.77 | |
BIST Electricity Turkey | 489.48 1.78 |
Investing Ideas
In addition to having EnVVeno Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare EnVVeno Medical
Compare EnVVeno Medical To Peers
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Return On Assets (0.37) | Return On Equity (0.59) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.